Stockreport

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis [Yahoo! Finance]

Lipella Pharmaceuticals Inc.  (LIPO) 
PDF biotechnology company addressing serious diseases with significant unmet need, today announced that the U.S. Food and Drug Administration (“FDA”) has granted a Type C me [Read more]